Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Conagen and Natáur to Produce Sustainable Natural Taurine


Today, Conagen Inc., a leading platform technology company with bio-manufacturing capabilities, and Natáur LLC, a producer of bio-based compounds, announced a partnership for the commercial production of a sustainable and natural source of taurine.

Natáur has used the tools of synthetic biology to allow microbes to make taurine, an essential nutrient for the health of humans and animals. Now, with the fermentation and manufacturing expertise of Conagen, the team has the capacity to produce taurine at the multi-ton scale needed to meet market demand.

Taurine is essential for cardiovascular, skeletal muscle, vision, and nervous system function. It is currently used as an ingredient in numerous products across several market sectors and product categories (food, feed, nutraceuticals, energy drinks, infant formula, pet foods, personal care) and the demand for taurine is growing as the awareness of its benefits increases. Taurine occurs naturally in meat and dairy products, but it is not made by plants, fungi or single-cell protein systems. In particular, as the world shifts to alternative, plant-based protein sources, taurine supplements are critical in supporting vegan and vegetarian diets.

Before Natáur’s proprietary manufacturing system was available, taurine was made in a process using fossil fuels, including oil and coal. That process creates toxic by-products, relies on a carcinogenic and hazardous air pollutant intermediate and releases high levels of CO2. In addition, taurine made from fossil fuels is primarily manufactured in China, which has recently led to supply chain challenges.

Natáur’s technology instead makes it possible for taurine to be produced sustainably by fermentation. This process relies on sugar and other natural feedstocks and does not use hazardous or toxic chemicals or animal parts. It reduces carbon emissions by 10x and makes it possible to produce taurine in volumes ranging from a few grams to thousands of tons, and in fermentation facilities located anywhere in the world, relieving supply chain challenges.

“We are thrilled to partner with Conagen on the sustainable production of taurine,” said Kathleen Turano, CEO of Natáur. “Conagen has the bio-manufacturing expertise and scale-up production capabilities to quickly get natural taurine into the marketplace.”

“We are impressed with the depth of knowledge and microbial engineering that Natáur has brought to natural taurine synthesis,” said Casey Lippmeier, Senior VP of Innovation at Conagen. “We are pleased to be partnering with them as we transition this market to the production of sustainable taurine.”

About Natáur

Natáur LLC develops sustainable solutions to replace petroleum-based compounds, with a focus on natural metabolites that play a beneficial role in human and animal health. Natáur’s technology produces bio-based compounds through the fermentation of safe microbes.

About Conagen

Conagen is making the impossible possible. We are a product-focused, synthetic biology R&D company with large-scale manufacturing service capabilities. Our proprietary strain development, fermentation, and scale-up technologies enhance the sales, production and profitability of our global partners across a broad spectrum of current and developing markets in food, beverage, nutrition, flavor and fragrance, pharmaceutical, and renewable materials.

For additional information visit http://www.nataur.com/ or contact Kathleen Turano, kturano@plant-ss.com

Share article on social media or email:

Bola AI and Curve Dental Partner to Integrate Voice Charting


News Image

Having the opportunity to work alongside the team at Curve Dental is an exciting prospect.

Bola Technologies, Inc. (Bola AI), a leading provider of voice-AI technology for healthcare and dental professionals, announces its partnership with Curve Dental, the leading provider of cloud-based dental solutions. The partnership allows the two companies to make Bola AI Voice Perio available to more than 50,000 dental professionals who use Curve SuperHero practice management software.

Bola AI’s Voice Perio system, which enables dental staff to seamlessly record periodontal data directly into client PMS and EHR systems in real time, will integrate directly with Curve’s SuperHero, the industry’s leading all-in-one practice management solution for independent practices and multisite/DSOs. The partnership enables individual practices and patients to lessen the burden on busy hygienists and additional office staff while simultaneously streamlining clinical documentation and administrative duties, including charting, scheduling, imaging, billing, payment processing and much more.

“Having the opportunity to work alongside the team at Curve Dental is an exciting prospect,” said Rushi Ganmukhi, CEO and founder of Bola AI. “Dental staffs have always had to make tradeoffs, such as working with less-comprehensive charts and less-efficient practice management systems, things that use up time that could be better put to use working with and educating patients. With Bola AI, our goal is to make all of that a thing of the past. Joining forces with Curve is another positive step in that direction.”

“We’re extremely excited to partner with Bola AI,” said Gary Long, Curve Dental’s chief revenue officer. “Our Curve SuperHero all-in-one solution makes practice management easy because it offers everything our customers need in one system. Bola AI’s voice technology is a great addition to our system because it simplifies periodontal charting, saving our customers time and resources.”

In recent years, AI and deep learning have made incredible strides, with computer vision, language processing and speech recognition achieving near-human levels. Bola AI’s Voice Perio delivers speech accuracy at 99% and allows for variable accents and flexible phrasing while filtering out background noise and nonclinical speech. Bola AI offers the first clinical voice assistant for the dental market to utilize this new age of technology while providing unprecedented ease of use and accuracy.

Curve Dental’s SuperHero software is designed to relieve staff of technical and administrative duties that can be more efficiently handled with an all-in-one PMS, allowing for a decrease in overhead and increasing opportunities for practices to grow their business.

For more information on the partnership, visit https://bola.ai/partners/curve-dental/.

About Bola AI

With Bola AI, the future of speech artificial intelligence (AI) is here. By harnessing the power of advanced technologies, this platform can provide efficient, fully integrated and accurate speech solutions for periodontal charting, clinical notes and more. With Bola AI, practices can empower themselves to create a smarter patient experience while improving operational efficiency and driving revenue. Get ready to revolutionize the way your practice operates with Bola AI. Bola AI is headquartered in Boston, MA. For more information, visit bola.ai.

About Curve Dental

Founded in 2004, Curve Dental provides the leading cloud-based practice management software for over 50,000 dental professionals across the United States and Canada. From the start, Curve has been singularly focused on the dental industry and is committed to delivering the best all-in-one dental practice management and patient engagement software for practices of all sizes. The company is privately held, with offices in Atlanta, Georgia; Provo, Utah; Calgary, Alberta; and Aberdeen, Scotland. Visit curvedental.com or call 1-888-910-HERO for more information.

Share article on social media or email:

Fine Dental Care in Wayne, NJ Announces Launch of New Website


Fine Dental Care in Wayne, NJ

Fine Dental Care in Wayne, NJ

Fine Dental Care is pleased to announce the launch of its new website at https://www.finedentalcare.com. The website was designed to give visitors easy access to information about services and procedures offered by Fine Dental Care and its affiliated providers. Visitors can also contact the office for appointments or request more information about the practice.

The new website was designed to bring a simple and easy-to-use experience to site visitors and patients of Fine Dental Care. The website is a resource for people interested in learning more about cosmetic dentistry and general dentistry procedures. The new website also includes a blog, which contains valuable and informative content on dental procedures and treatments. Visitors can easily find information about the practice and its offerings, while patients can book appointments online, request an appointment online, or simply contact the office.

The practice is led by Dr. Bruce Fine, a board-certified dentist who holds multiple fellowships, including the Academy of General Dentistry, the International Congress of Implantology, and the Institute for Advanced Laser Dentistry. With over three decades of experience, Dr. Fine is committed to upholding the highest standards of patient care and has a reputation for providing the best possible treatment to his patients.

Dr. Fine is joined by a team of dental professionals who are committed to providing their patients with the highest level of care. The practice is equipped with the latest technologies, including a 3D scanner that is highly diagnostic and less radiation than traditional x-rays, digital x-rays, and intraoral cameras to help Dr. Fine provide an accurate diagnosis and treatment plan for each patient.

Fine Dental Care offers a range of dental services, including general dentistry, cosmetic dentistry, implantology, root canal therapy, and more. Some of the services provided by the practice include:


  • General dentistry: This refers to general dental care, including cleanings, diagnostics, extractions, and wisdom tooth removal.
  • Restorative dentistry: This type of dentistry addresses dental concerns and includes root canals, dental bridges and crowns, fillings, dental implants, and gum rejuvenation
  • Cosmetic dentistry: Cosmetic dentistry is intended to improve the appearance of teeth and includes Invisalign, teeth whitening, and veneers.
  • Pediatric dentistry: Pediatric dentistry refers to children’s dentistry and includes the first dental checkup, sealants, fillings, and x-rays
  • Dental implants: The practice offers multiple dental implant options, including same-day implants using 3-D imaging and All-on-4 full arch replacement.
  • Periodontics: Periodontal treatments may include root scaling and planing, gum graft surgery, sinus lifts, and more, including LANAP, a laser technique that regenerates bone lost due to gum disease.
  • Dental emergencies: The practice provides emergency dental care for oral emergencies, including chipped or broken teeth, knocked out teeth, abscesses, soft tissue injuries, and missing or damaged restorations
  • Sedation: Fine Dental Care offers multiple sedation options for those who suffer from dental anxiety including oral sedation and laughing gas.

About Fine Dental Care

Fine Dental Care is a premier dental clinic located in Wayne, New Jersey, at 600 Valley Road Ste LLL1. To make an appointment, call 973-633-5440 or book an appointment online at https://www.finedentalcare.com.

Share article on social media or email:

Genetic Causes of Three Previously Unexplained Rare Diseases Identified


The image shows a mutated form of a protein present in some lymphedema patients (green) and cell nuclei (blue). Normally, the protein exists only inside the nuclei of cells.

New York, NY (March 16, 2023) – Using a new computational approach they developed to analyze large genetic datasets from rare disease cohorts, researchers at the Icahn School of Medicine at Mount Sinai and colleagues have discovered previously unknown genetic causes of three rare conditions: primary lymphedema (characterized by tissue swelling), thoracic aortic aneurysm disease, and congenital deafness. The work was done in collaboration with colleagues at the University of Bristol, UK; KU Leuven, Belgium; the University of Tokyo; the University of Maryland; Imperial College London, and others from around the world.

An enhanced understanding of the functions of the genes involved in these and other disorders could pave the way for the development of treatments. The findings were published in the March 16 online issue of Nature Medicine DOI: 10.1038/s41591-023-02211-z.

Rare diseases affect approximately 1 in 20 people, but only a minority of patients receive a genetic diagnosis. Fewer than half of the 10,000 recorded rare diseases have a known genetic cause. Genome sequencing of large cohorts of rare disease patients provides a route toward discovering the genetic causes that remain unknown. However, large genetic datasets are challenging to work with, slowing down research significantly, say the investigators.

“While rare diseases are individually rare, collectively they are quite common. It is important for our understanding of human biology and for the development of diagnostics and therapeutics that the remaining causes are found,” said senior study author Ernest Turro, PhD, Associate Professor of Genetics and Genomics Sciences at Icahn Mount Sinai. “Many people with a rare disease struggle for many years to obtain a genetic diagnosis. By developing and applying statistical methods and computational approaches to find new causes of rare diseases, we hope to expand knowledge of the underlying causes of these diseases, hasten the time to diagnosis for patients, and pave the way for the development of treatments.”

The investigators studied a collection of 269 rare disease classes using data from 77,539 participants in the 100,000 Genomes Project, one of the largest datasets of phenotyped and whole-genome-sequenced rare disease patients. The researchers identified 260 associations between genes and rare disease classes, including 19 associations previously absent from the literature. Through an international academic collaboration, the authors validated the three most plausible novel associations by identifying additional cases in other countries and through experimental and bioinformatic approaches.

“We hope that our computational framework will help accelerate the discovery of the remaining unknown etiologies of rare diseases across the board. For now, we expect that a genetic diagnosis will be attainable for certain families with previously unexplained primary lymphedema, thoracic aortic aneurysm disease, and deafness,” said Daniel Greene, PhD, a postdoctoral fellow at Icahn Mount Sinai and lead author of the study. “We also plan to apply our methods in novel ways and in other datasets, with the aim of continuing to unravel the genetic causes of rare diseases.”    

The paper is titled “Genetic association analysis of 77,539 genomes reveals rare disease etiologies.”

For the complete list of authors, and details on funding, see the paper at https://www.nature.com/articles/s41591-023-02211-z.

The National Organization for Rare Disorders has designated the Division of Medical Genetics and Genomics at The Mount Sinai Hospital as a Rare Disease Center of Excellence.

####

About the Icahn School of Medicine at Mount Sinai

The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the eight- member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to a large and diverse patient population.

Ranked 14th nationwide in National Institutes of Health (NIH) funding and among the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges, Icahn Mount Sinai has a talented, productive, and successful faculty. More than 3,000 full-time scientists, educators, and clinicians work within and across 34 academic departments and 35 multidisciplinary institutes, a structure that facilitates tremendous collaboration and synergy. Our emphasis on translational research and therapeutics is evident in such diverse areas as genomics/big data, virology, neuroscience, cardiology, geriatrics, as well as gastrointestinal and liver diseases.

Icahn Mount Sinai offers highly competitive MD, PhD, and Master’s degree programs, with current enrollment of approximately 1,300 students. It has the largest graduate medical education program in the country, with more than 2,000 clinical residents and fellows training throughout the Health System. In addition, more than 550 postdoctoral research fellows are in training within the Health System.

A culture of innovation and discovery permeates every Icahn Mount Sinai program. Mount Sinai’s technology transfer office, one of the largest in the country, partners with faculty and trainees to pursue optimal commercialization of intellectual property to ensure that Mount Sinai discoveries and innovations translate into health care products and services that benefit the public.

Icahn Mount Sinai’s commitment to breakthrough science and clinical care is enhanced by academic affiliations that supplement and complement the School’s programs.

Through the Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai. Additionally, MSIP develops research partnerships with industry leaders such as Merck & Co., AstraZeneca, Novo Nordisk, and others.

The Icahn School of Medicine at Mount Sinai is located in New York City on the border between the Upper East Side and East Harlem, and classroom teaching takes place on a campus facing Central Park. Icahn Mount Sinai’s location offers many opportunities to interact with and care for diverse communities. Learning extends well beyond the borders of our physical campus, to the eight hospitals of the Mount Sinai Health System, our academic affiliates, and globally.

——————————————————-

  • Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Beth Israel; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.

Healthcare Pearls Launches to Provide Patient-Centered Actionable Insights for Health & Wellness Improvement


Healthcare Pearls logo

Healthcare Pearls from Dr. Jerry Williams, MD

Healthcare Pearls courses provide actionable insights and guidance to help participants become their own best health advocates. We are confident that our program will make a real difference in people’s lives. We want to help patients help their doctors.

UrgentCare 24/7 CEO and Founder Jerry K. Williams, MD, is proud to announce the launch of Healthcare Pearls, a series of online informational guidance courses designed to help individuals better their health and wellness. With Healthcare Pearls, participants can take charge of their health by learning valuable tools for improvement, creating effective health plans, and becoming their own best health advocates.

According to UrgentCare 24/7 founder Dr. Williams, taking control of one’s health is the key to better outcomes and overall well-being. By becoming knowledgeable about health issues and conditions, individuals can make confident healthcare choices and participate actively in their healthcare decisions. Healthcare Pearls offer an avenue to understanding symptoms, conditions, diagnosis, and treatment options, saving participants from lengthy research that can be tiring and time-consuming.

Healthcare Pearls online courses are designed to make medical terms accessible and easily understood. Participants will be prepared to ask questions during doctor visits and gain a better understanding of approaches and options for recovery and maintenance of their health issues. With Healthcare Pearls, individuals can avoid scrolling through countless articles and conflicting information and trust a reliable source of guidance.

“We are excited to offer Healthcare Pearls to individuals looking to take control of their health,” said Dr. Williams. “Our courses provide actionable insights and guidance that can help participants become their own best health advocates, and we are confident that our program will make a real difference in people’s lives. We want to help patients help their doctors.”

Share article on social media or email:

Elite Endodontics of NH Announces the Opening of Two Offices in Hooksett and Hudson, NH


Elite Endodontics of New Hampshire

Elite Endodontics of New Hampshire

We are dedicated to providing our patients with gentle and compassionate endodontic care. We take the time to listen and educate our patients about their oral health so they can make educated decisions about their treatment options.

Elite Endodontics of New Hampshire (https://www.eliteendodonticsnh.com) is pleased to announce the grand opening of two state-of-the-art new offices in Hooksett and Hudson, New Hampshire. The Hooksett office is located at 1310 Hooksett Road, while the Hudson office is located at 182 Central Street.

Elite Endodontics of New Hampshire is excited about the addition of these offices, which will help them better serve their patients throughout New Hampshire with faster service times and more advanced technology. Both offices will offer a full range of services to meet the dental needs of patients throughout the region, including root canal therapy, surgical endodontics, cosmetic dentistry, and more.

The practice is led by a team of dedicated professionals committed to providing high-quality endodontic and dental services. Dr. Lily Hu is a board-certified dentist and anesthesiologist and is the Director of Anesthesia and Pain Control at Tufts University School of Dental Medicine. Dr. Tadros M. Tadros, an endodontic specialist, is a Diplomate of the American Board of Endodontics and is currently an instructor at Tufts University School of Dental Medicine. Dr. Anika Solanki is a board-eligible endodontist and an active member of the American Association of Endodontists (AAE) and the American Dental Association (ADA).

“We are dedicated to providing our patients with gentle and compassionate endodontic care,” said Dr. Tadros. “We take the time to listen and educate our patients about their oral health so they can make educated decisions about their treatment options.”

The highly committed dental professionals of Elite Endodontics of New Hampshire are committed to providing their patients with the highest quality of care and education. They are joined by a team of experienced and friendly dental assistants who strive to provide patients with the best possible experience. In addition, the qualified staff will work closely with you to ensure that all your questions are answered, helping you feel comfortable and confident in your treatment plan.

Elite Endodontics of New Hampshire is equipped with the latest in dental and endodontic technology, including cone beam scanner 3D imaging, intraoral cameras, electronic apex locators, and more. Both offices offer a range of services, including:

  • Root canal therapy, including GentleWave root canal treatment
  • Endodontic retreatment for past root canals
  • Endodontic or apical microsurgery
  • Cracked teeth treatment
  • Dental trauma treatment for teeth that have been knocked out, chipped, cracked, or fractured
  • Pulpotomies to treat infected baby teeth

To help patients feel more comfortable during their visits, Elite Endodontics of New Hampshire offers a range of sedation options. Patients can choose from nitrous oxide, otherwise known as laughing gas, conscious oral sedation, or IV sedation.

About Elite Endodontics of New Hampshire

Elite Endodontics of New Hampshire is a premier endodontics practice with offices in Hooksett and Hudson, NH. To make an appointment at the Hooksett office, call 603-628-2891. For the Hudson office, call 603-882-5455. Or, request an appointment online at https://www.eliteendodonticsnh.com.

Share article on social media or email:

Chang Dental Group Announces Launch of Redesigned Website


Chang Dental Group, Natick and Framingham, MA

Chang Dental Group

We want to provide our patients with all the information they need to make the best decisions about their oral health. The new website is an extension of our commitment to providing the best care possible and making it easy for our patients to find that care.

Chang Dental Group is pleased to announce the launch of its newly redesigned website, https://www.changdentalgroup.com. The newly redesigned site is more accessible, with a clean, user-friendly interface that puts patients first as well as offers more information and resources to potential patients. The site also includes helpful videos and articles that explain treatments in plain English.

Chang Dental Group offers options for patients who are looking for greater comfort and convenience in the dental experience. A new feature of the website is an online appointment request form, which allows those who want to schedule an appointment with Chang Dental to do so quickly and easily.

Chang Dental Group is a Massachusetts-based dental practice with offices in Natick and Framingham. Chang Dental Group has been rated highly on Google by its patients, and the practice prides itself on offering compassionate, gentle, and top-of-the-line dental care.

Chang Dental Group is led by Founder and CEO Dr. Jenny Chang, a prosthodontist who specializes in the aesthetic rejuvenation of teeth. Dr. Chang graduated Magna Cum Laude from Harvard Dental School of Dental Medicine and then continued her studies, receiving her degree in Prosthodontics also from Harvard School of Dental Medicine. Nationally recognized for her skill and expertise, Dr. Chang was awarded the Dentist Scientist Award from the National Institute of Health.

“We want to provide our patients with all the information they need to make the best decisions about their oral health,” said Dr. Jenny Changer, owner and founder of Chang Dental Group. “The new website is an extension of our commitment to providing the best care possible and making it easy for our patients to find that care.”

Dr. Chang is joined by a team of dedicated dental health professionals including fellow prosthodontists, periodontists, dentists, orthodontists, endodontists, and hygienists who are committed to providing the highest level of care. Chang Dental Group offers over 50 services throughout its two locations. Services offered at Chang Dental Group’s two locations include:

  • General dentistry: General dentistry refers to preventative care like cleanings, exams, x-rays, and more.
  • Laser cleaning: Laser cleaning is used to deeply clean the gums and bone to avoid tooth loss or extraction.
  • Orthodontics: Invisalign straightens the teeth without the need for traditional braces
  • Pediatric dentistry: Chang Dental Group can make sure children are set up for a lifetime of good oral hygiene
  • Dental implants: Dental implants are a permanent solution to replace missing or damaged teeth and improve the appearance of the teeth.
  • Teeth whitening: Chang Dental Group uses Glo Whitening to safely and effectively whiten the teeth

Chang Dental Group strives to make quality dental care affordable and accessible to all patients by offering comprehensive dental care memberships for $149 a year. The yearly membership includes two cleanings, two oral exams, two x-rays, and 20% off other additional procedures. With the membership, there are no yearly maximums, waiting periods, deductibles, or surprise copayments.

About Chang Dental Group

Chang Dental Group is a top-rated dentist in Massachusetts and has two locations: 220 N. Main Street, Suite 203, Natick MA 01760 and 1671 Worcester Rd., Suite 401, Framingham MA 01701. For the Framingham location, call ​​(508) 405-1100. For the Natick location, call (508) 653-0444. To schedule an appointment online, visit https://www.changdentalgroup.com.

Share article on social media or email:

Custom Surgical Launches New Generation of MicroREC for Digitizing Microscopes and Slit Lamps


custom-surgical-smartphone-microscope-slit lamp

MicroREC digitizes your microscope or slit lamp for seamless microscopy imaging recording and instant streaming or sharing.

Already in use by over 1,000 prominent ophthalmic surgeons and educators in 65 countries, MicroREC enables digital collaboration in ophthalmics through the capture, management, and sharing of images, 8k videos, and even live surgeries among colleagues, educators, and students on a global scale.

Custom Surgical, the provider of the award-winning optical system that quickly and easily digitizes microscopes and slit lamps, announces the pre-sales of the next generation of MicroREC. Ophthalmologists leverage MicroREC to effortlessly capture the highest quality images and videos of diagnoses or procedures.

The new MicroREC features:


  • An aluminum frame to withstand heavy use
  • Better construction for improved image quality

Already in use by over 1,000 prominent ophthalmic surgeons and educators in 65 countries, MicroREC enables digital collaboration in ophthalmics through the capture, management, and sharing of images, 8k videos, and even live surgeries among colleagues, educators, and students on a global scale. MicroREC is fully compatible with over 80% of microscopes and slit lamps and 100% of smartphones on the market.

Surgeons, clinicians, and educators use MicroREC to:

  • Digitize their practices
  • Improve practice management with simplified workflows
  • Consult on live surgeries and remote training sessions
  • Collaborate with peers via media sharing, screen sharing, and mirroring

Federico Acosta, co-founder and CEO of Custom Surgical, says, “The new MicroREC is a big step forward. With the popularity and heavy use of the original MicroREC, the new version meets evolving customers’ needs and is built to last for decades while maintaining the highest quality images with German-made optics.”

Leading ophthalmic surgeons use the MicroREC in every kind of ophthalmic procedure and slit lamp examinations. The new version of the MicroREC is now available for pre-order at customsurgical.co.

ABOUT CUSTOM SURGICAL

At Custom Surgical, our mission is to democratize healthcare by creating affordable medical imaging solutions. Our award-winning MicroREC optical system makes it easy and affordable for medical professionals to collect, organize, and share their expertise worldwide, improving access for better patient outcomes. Learn more at https://customsurgical.co.

Share article on social media or email:

KitoTech Medical Inc. Launches Wound Repair Kit to Stop Bleeding and Close Wounds for Consumers


The kit is a convenient and cost-effective all-in-one solution for consumers to repair a broad range of wounds, including serious cuts, lacerations, and skin tears, and to avoid the expense and inconvenience of ER visits.

KitoTech Medical has introduced a new product to consumers, microMend® 2-in-1 Wound Repair Kit, that combines its microMend® wound closure device with Beeken Biomedical’s hemostatic dressing, NuStat®, to stop bleeding. Both microMend and NuStat products are widely used by physicians and hospitals to treat wounds.

The 2-in-1 Wound Repair Kit represents the first expansion of KitoTech’s product line beyond wound closure and addresses the two most critical issues in wound repair – stopping the bleeding and closing the wound. It is a convenient and cost-effective all-in-one solution for consumers to repair a broad range of wounds, including serious cuts, lacerations, and skin tears, and to avoid the expense and inconvenience of ER visits.

“We are excited about the opportunity to partner with Beeken Biomedical to provide a kit that includes one of the leading products to stop bleeding, NuStat®, with our microMend® wound closure device,” said Ron Berenson, MD, President and CEO. “The combination provides one of the few kits on the market that contain the advanced medical grade products required to repair serious, and it demonstrates our ongoing commitment to provide comprehensive solutions for wound treatment.”

About microMend®

microMend and microMend PRO products comprise an array of miniature staples (Microstaples) attached to an adhesive backing that combines the holding strength of a suture with the simplicity of applying a bandage. microMend PRO provides medical personnel with a cost-effective, time saving and easy-to-use option for closing lacerations, surgical incisions, and other wounds. microMend’s line of consumer products makes it possible for individuals to close lacerations at home, in the outdoors or elsewhere without the inconvenience and costs associated with ER and Urgent Care Clinic visits.

About KitoTech Medical

KitoTech Medical is a medical device company spun out of the University of Washington that is using its patented Microstaple Technology platform to develop and commercialize products for wound closure and wound care. Additional product and company information can be found online at http://www.micromendskinclosure.com.    

About Beeken Biomedical

Beeken Biomedical, the developer of NuStat®, is a medical device company dedicated to the advancement of bleeding control. Its innovative Hemafiber® Technology enables civilians, first responders and healthcare providers to rapidly control bleeding to improve patient outcomes for blood loss. Find additional product and company information online at http://www.beekenbiomedical.com.

Follow KitoTech Medical on social media at https://www.linkedin.com/company/kitotech-medical-inc./

Share article on social media or email:

Rapid Novor’s Blood Test for Multiple Myeloma Monitoring is CLIA Certified for Clinical Use in the US


Abir Khaled, Multiple Myeloma Senior Research Scientist at Rapid Novor

Abir Khaled, Multiple Myeloma Senior Research Scientist at Rapid Novor

The non-invasive and highly sensitive nature of EasyM™ makes it an ideal assay to assess MRD status as an efficacy endpoint for clinical trials of novel therapeutic drugs.

Rapid Novor Inc., the world’s leader in mass spectrometry (MS)-based antibody protein sequencing, announced today that its diagnostic laboratory obtained the Clinical Laboratory Improvement Amendments (CLIA) certification for their EasyM™ assay as a Laboratory Developed Test (LDT). EasyM™ is the world’s first personalized blood test for Multiple Myeloma to receive such certification. This means clinicians now have access to a simple blood test for highly sensitive measurable residual disease (MRD) monitoring of multiple myeloma.

Multiple myeloma is the second most common form of hematological (blood) cancer with ~175,000 new cases worldwide each year. The presence of MRD is an important prognostic factor for multiple myeloma and typically requires ongoing assessments for detection and monitoring of disease progression. However, current clinical tests for MRD often lack the sensitivity or require the invasive, expensive, and time-intensive practice of bone marrow biopsies – putting physical and financial burden on the patients.

“The CLIA certification for EasyM™ is a major milestone in multiple myeloma MRD testing,” said Dr. Liqiang Yang, Chief Strategy Officer at Rapid Novor. “EasyM™ now provides a much-needed option for patients with multiple myeloma who can benefit from frequent monitoring of their disease especially during the complete remission (CR) stage without invasive bone-marrow aspirates. The non-invasive and highly sensitive nature of EasyM™ makes it an ideal assay to assess MRD status as an efficacy endpoint for clinical trials of novel therapeutic drugs.”

The EasyM™ assay measures the levels of M-protein, a well-known biomarker for multiple myeloma, using Rapid Novor’s proprietary MS-based protein sequencing technology. EasyM™ can improve the way the disease is monitored to foster informed decisions on potential therapies and treatment regimens. Data from retrospective clinical studies suggest that EasyM™ could provide earlier predictions of relapse compared to conventional methods.

The CLIA certification of Rapid Novor’s Diagnostic Laboratory means that patients in the US diagnosed with multiple myeloma will now be able to access EasyM™ as a clinical testing option for enhanced disease monitoring. Rapid Novor is currently in the process of obtaining certification of the EasyM™ assay within Canada to bring this non-invasive, sensitive, clinical test to Canadian patients with multiple myeloma.

About Rapid Novor Diagnostic Laboratory

Rapid Novor Diagnostic Laboratory is a business unit of Rapid Novor Inc.

For more information, please visit http://www.easym.com.About Rapid Novor Inc.

Rapid Novor Inc., is the world’s leader in antibody protein sequencing technology. Specializing in the field of mass spectrometry-based proteomics, the team has developed the technology to directly sequence antibody proteins without needing access to the producing cell line. Located at the Kitchener-Waterloo high-tech hub, the company continues to build its technology portfolios based on years of scientific research and inventions. The company’s mission is to elevate human health by decoding immunity. For more information, please visit http://www.rapidnovor.com. Follow the company on Twitter @rapidnovor or LinkedIn.

Share article on social media or email: